Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.
invested by AbbVie in Australian medical research and clinical trials in 2017
A Portfolio of Medicines
We aim to develop innovative therapies for health conditions where there is a significant need. Our medicines are approved by the Therapeutic Goods Administration (TGA) for use in Australia.
products with potential for new drug or indication approvals by the end of 2020
programs in Phase III under way
scientists working globally to make a difference
patients have enrolled in AbbVie Clinical Trials in Australia over
the last 10 years
Make New Medicines Possible
Whether you or a relative are interested in participating in a trial, our Clinical Trials and Me website can help address your questions. It offers information about clinical trials and lists our current clinical trials. You’ll also learn how to prepare for one and what to expect during and after a clinical trial.
In this episode we unpack the story of scientific discovery and medicine development in rheumatoid arthritis. Arthritis has been known to mankind for thousands of years. And yet, in our lifetime, innovation in medicine has completely changed the care and treatment of it. Forever.